SCHEMBL4245199

SCHEMBL4245199

O=C(c1ccc(O)c(O)c1)c1c(O)cc(O)c(O)c1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.52
CA1 P00915 3/20 0.52
CA2 P00918 3/20 0.52
CA7 P43166 3/20 0.52
CA9 Q16790 3/20 0.52
CA14 Q9ULX7 3/20 0.52
KDM4E B2RXH2 2/20 0.52
GAA P10253 2/20 0.52
POLB P06746 1/20 0.52
MAPT P10636 1/20 0.52
CA4 P22748 1/20 0.52
CA6 P23280 1/20 0.52
PTGS2 P35354 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
SYNJ2 O15056 1/20 0.51
SIRT1 Q96EB6 1/20 0.49
HDAC1 Q13547 1/20 0.48
HDAC6 Q9UBN7 1/20 0.47
DBH P09172 1/20 0.46
RECQL P46063 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21935558 0.90 CA12 (0.58) CA12CA1CA2CA7CA9
SCHEMBL724972 0.85 KDM4E (0.59) CA12CA1CA2CA7CA9
SCHEMBL19003452 0.83 CA12 (0.56) CA12CA1CA2CA7CA9
SCHEMBL10589365 0.81 FASN (0.62) CA12CA1CA2CA7CA9
SCHEMBL7896049 0.80 FFAR1 (0.44) CA12CA1CA2CA7CA9
SCHEMBL1758192 0.80 CA12 (0.68) CA12CA1CA2CA7CA9
SCHEMBL21935553 0.79 HDAC1 (0.47) CA12CA1CA2CA7CA9
Maclurin SCHEMBL29523046 0.79 SYNJ2 (0.69) CA12CA1CA2CA7CA9
Maclurin SCHEMBL758337 0.79 SYNJ2 (0.69) CA12CA1CA2CA7CA9
SCHEMBL1918258 0.78 HDAC1 (0.61) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10894887-B2 Composition for forming film protecting against aqueous hydrogen peroxide solution NISSAN CHEMICAL CORPORATION (JP) 2021-01-19 US disclosed
US-20200131376-A1 COMPOSITION FOR FORMING FILM PROTECTING AGAINST AQUEOUS HYDROGEN PEROXIDE SOLUTION NISSAN CHEMICAL CORPORATION (JP) 2020-04-30 US disclosed
US-8241822-B2 Halogenated oxime derivatives and the use therof as latent acids BASF SE (DE) 2012-08-14 US disclosed
US-20090042114-A1 Halogenated oxime derivatives and the use therof as latent acids YAMATO HITOSHI 2009-02-12 US disclosed
US-5308743-A USED IN THE MANUFACTURE OF SEMICONDUCTORS AND ELECTRONIC DEVICES FUJI PHOTO FILM CO., LTD. (JP) 1994-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042114-A1 Halogenated oxime derivatives and the use therof as latent acids AHR, CCNT1, RTF1 CA12 1387/4885CA1 1349/4885CA2 2829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.